BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30251155)

  • 21. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
    Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry.
    Kim E; Kim H; Suh K; Kwon S; Lee G; Park NH; Hong J
    Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1183-95. PubMed ID: 23650031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling and identification of the metabolites of calycosin in rat hepatic 9000×g supernatant incubation system and the metabolites of calycosin-7-O-β-D-glucoside in rat urine by HPLC-DAD-ESI-IT-TOF-MS(n) technique.
    Zhang YZ; Xu F; Dong J; Liang J; Hashi Y; Shang MY; Yang DH; Wang X; Cai SQ
    J Pharm Biomed Anal; 2012 Nov; 70():425-39. PubMed ID: 22766358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolite identification of AZD8055 in Sprague-Dawley rats after a single oral administration using ultra-performance liquid chromatography and mass spectrometry.
    Rashid MM; Oh HA; Lee H; Jung BH
    J Pharm Biomed Anal; 2017 Oct; 145():473-481. PubMed ID: 28743078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LC/MS/MS for identification of in vivo and in vitro metabolites of jatrorrhizine.
    Zhang Y; Wu W; Han F; Chen Y
    Biomed Chromatogr; 2008 Dec; 22(12):1360-7. PubMed ID: 18651596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of in vitro and in vivo fidarestat metabolites: Toxicity and efficacy evaluation of metabolites.
    Borkar RM; Gajji S; Mohammed SA; Srivastava M; Reddy VG; Jala A; Asthana S; Kamal A; Banerjee SK; Ragampeta S
    J Mass Spectrom; 2021 Feb; 56(2):e4694. PubMed ID: 33410180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites.
    Chavan BB; Tiwari S; G S; Nimbalkar RD; Garg P; R S; Talluri MVNK
    J Pharm Biomed Anal; 2018 Aug; 157():59-74. PubMed ID: 29772457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolite characterization of ambrisentan, in in vitro and in vivo matrices by UHPLC/QTOF/MS/MS: Detection of glutathione conjugate of epoxide metabolite evidenced by in vitro GSH trapping assay.
    Johnsi Rani P; Vishnuvardhan C; Nimbalkar RD; Garg P; Satheeshkumar N
    J Pharm Biomed Anal; 2018 Jun; 155():320-328. PubMed ID: 29684813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study.
    Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
    PLoS One; 2015; 10(8):e0134027. PubMed ID: 26244343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of reactive intermediates formation in dacomitinib metabolism and bioactivation pathways elucidation by LC-MS/MS:
    Attwa MW; Kadi AA; Abdelhameed AS
    RSC Adv; 2018 Nov; 8(68):38733-38744. PubMed ID: 35558335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC-ESI/MS.
    Szultka M; Krzeminski R; Jackowski M; Buszewski B
    Chromatographia; 2014; 77(15):1027-1035. PubMed ID: 25089048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural characterization of in vitro metabolites of the new anticancer agent EAPB0503 by liquid chromatography-tandem mass spectrometry.
    Lafaille F; Solassol I; Enjalbal C; Bertrand B; Doulain PE; Vappiani J; Bonnet PA; Deleuze-Masquéfa C; Bressolle FM
    J Pharm Biomed Anal; 2014 Jan; 88():429-40. PubMed ID: 24176748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and structural characterization of in vivo metabolites of ketorolac using liquid chromatography electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS).
    Raju B; Ramesh M; Borkar RM; Padiya R; Banerjee SK; Srinivas R
    J Mass Spectrom; 2012 Jul; 47(7):919-31. PubMed ID: 22791260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive intermediates in naquotinib metabolism identified by liquid chromatography-tandem mass spectrometry: phase I metabolic profiling.
    Attwa MW; Kadi AA; AlRabiah H; Darwish HW
    RSC Adv; 2019 Mar; 9(18):10211-10225. PubMed ID: 35520926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the Phase II metabolites of rutaecarpine in rat by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Lee SK; Lee DW; Jeon TW; Jin CH; Kim GH; Jun IH; Lee DJ; Kim SI; Kim DH; Jahng Y; Jeong TC
    Xenobiotica; 2005 Dec; 35(12):1135-45. PubMed ID: 16418066
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Alsubi TA; Attwa MW; Bakheit AH; Darwish HW; Abuelizz HA; Kadi AA
    RSC Adv; 2020 Jun; 10(38):22668-22683. PubMed ID: 35514564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Belizatinib: Novel reactive intermediates and bioactivation pathways characterized by LC-MS/MS.
    Attwa MW; Kadi AA; Darwish HW
    J Pharm Biomed Anal; 2019 Jul; 171():132-147. PubMed ID: 30999224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring in vitro, in vivo metabolism of mogroside V and distribution of its metabolites in rats by HPLC-ESI-IT-TOF-MS(n).
    Xu F; Li DP; Huang ZC; Lu FL; Wang L; Huang YL; Wang RF; Liu GX; Shang MY; Cai SQ
    J Pharm Biomed Anal; 2015 Nov; 115():418-30. PubMed ID: 26280925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
    Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.